A significant bottleneck in cardiovascular regenerative medicine is the identification of a viable source of stem/progenitor cells that could contribute new muscle after ischaemic heart disease and acute myocardial infarction1. A therapeutic ideal—relative to cell transplantation—would be to stimulate a resident source, thus avoiding the caveats of limited graft survival, restricted homing to the site of injury and host immune rejection. Here we demonstrate in mice that the adult heart contains a resident stem or progenitor cell population, which has the potential to contribute bona fide terminally differentiated cardiomyocytes after myocardial infarction. We reveal a novel genetic label of the activated adult progenitors via re-expression of a key embryonic epicardial gene, Wilm’s tumour 1 (Wt1), through priming by thymosin β4, a peptide previously shown to restore vascular potential to adult epicardium-derived progenitor cells2 with injury. Cumulative evidence indicates an epicardial origin of the progenitor population, and embryonic reprogramming results in the mobilization of this population and concomitant differentiation to give rise to de novo cardiomyocytes. Cell transplantation confirmed a progenitor source and chromosome painting of labelled donor cells revealed transdifferentiation to a myocyte fate in the absence of cell fusion. Derived cardiomyocytes are shown here to structurally and functionally integrate with resident muscle; as such, stimulation of this adult progenitor pool represents a significant step towards resident-cell-based therapy in human ischaemic heart disease.
At a glance
Two previous studies have indicated a significant contribution of embryonic epicardial progenitor cells (EPDCs) to the cardiomyocyte lineage3, 4. We investigated a basis for translating this myocardial potential in the adult heart. A significant problem in this regard is the lack of current adult epicardium-specific markers and authentic adult EPDC–Cre-expressing mouse strains for canonical lineage tracing. Previously reported genetic models to trace, or target, cells originating in the epicardium, such as Wt1GFPCre/+ and Wt1CreERT2/+; R26REYFP/+ mice or Tbx18Cre mice3, 4, cannot be applied directly to their adult counterparts, as the epicardial markers are either restricted to embryonic stages (Supplementary Fig. 1) or additionally expressed in the myocardium, as in the case of the Tbx18 model5. Therefore, we sought to reactivate Wt1 expression in the adult heart by pre-treatment (‘priming’) with thymosin β4 (Tβ4), which we previously showed induces adult EPDCs to form vascular precursors for neovascularization2, 6, followed by myocardial infarction (see schematic, Fig. 1a). Thus, we were able to establish both constitutive (GFP+) and pulse (YFP+) labelling of Wt1+ progenitors to characterize the potential spatiotemporal distribution of primed adult cardiomyocyte precursors.
We initially established epicardial explants from Tβ4-primed Wt1GFPCre/+ adult hearts (7 days of intraperitoneal injections without myocardial infarction; Supplementary Fig. 2a–d) as previously described2, 7 and investigated Isl1 expression as a marker of postnatal cardioblasts8 along with Nkx2-5, an early marker of cardiomyocyte progenitors9, 10, 11. Isl1+/GFP+ cells and Nkx2-5+/GFP+ cells were prevalent within the explant cultures with mean percentage incidences of 76.7 ± 6.3% and 7.2 ± 2.1%, respectively (mean percentage ± standard error of mean (s.e.m.); n = 12 explants), as were progenitor-like GFP+ cells, which expressed more mature markers of cardiomyocyte differentiation such as cardiac troponin T (cTnT, also known as Tnnt2; 4.1 ± 1.6%; Supplementary Fig. 2i, j) sarcomeric α-actinin (SαA; 4.8 ± 2.4%; Supplementary Fig. 2l, m) and cardiac myosin binding protein C (MyBPC, also known as Mybpc2; 4.6 ± 0.8, mean percentage ± s.e.m.; Supplementary Fig. 2o, p). By day 14 in culture, cells adopted a more differentiated cardiac muscle phenotype; with evidence of sarcomeric structure in conjunction with compartmentalization of the GFP signal (Supplementary Fig. 2k–r).
Next we determined the extent of Wt1 re-expression in vivo alongside the quantity and distribution of GFP+ and YFP+ adult progenitors. With injury alone (no Tβ4 priming), expression of Wt1 and Tbx18 was significantly increased at day 7 after myocardial infarction, dependent on the severity of the injury (Supplementary Fig. 3a). Following Tβ4 priming, expression of both epicardial genes was precociously increased by day 2 after myocardial infarction (Supplementary Fig. 3b), and this persisted in Tβ4-primed GFP+ cells isolated by fluorescence-activated cell sorting (FACS) at day 4 after injury (Supplementary Fig. 4a). In situ hybridization, at an equivalent stage, revealed an upregulation in Wt1 expression in small round ‘progenitor-like’ cells within the epicardium, subepicardial region and underlying myocardium (Supplementary Fig. 4b–d).
Tβ4 priming resulted in significantly more sorted GFP+ and YFP+ cells from whole hearts taken at day 7 after myocardial infarction when compared to treatment with vehicle (Fig. 1b–e and Supplementary Fig. 5a–d; GFP, 6.12% +Tβ4 versus 3.38% +PBS; YFP, 0.74% +Tβ4 versus 0.36% +PBS). This was confirmed in situ by anti-GFP immunostaining on serial heart sections at the equivalent stage after injury (Supplementary Fig. 5e). Further flow cytometry characterization of a progenitor phenotype revealed that labelled cells, at day 4, were not c-Kit+ (Supplementary Fig. 6a–e). Instead, approximately 80% were positive for stem cell antigen factor 1 (Sca-1+; Supplementary Fig. 6f–j), consistent with the notion that the adult epicardium is a heterogeneous lineage12.
Two-photon molecular excitation laser scanning microscopy revealed pulse-labelled YFP+ cells in the epicardium and subepicardial region at day 7 after myocardial infarction (Fig. 1f, g), distributed in diminishing numbers towards the underlying myocardium (Fig. 1h). Proliferative Ki67+ progenitors were observed in epicardial and subepicardial regions (Supplementary Fig. 7a, b) alongside YFP+ cells positive for phospho-histone H3 (Supplementary Fig. 7c–f), which expanded in number from day 2–14 (Supplementary Fig. 7g–m). A subpopulation, residing in the epicardium, was positive for Isl1 and Nkx2-5 at day 2 after myocardial infarction (Fig. 1i–m and Supplementary Fig. 8a–d) and these cardiac progenitors significantly increased by day 7 after myocardial infarction (Fig. 1n). By day 14, YFP+ cells were located within the border zone and peri-infarct region (Fig. 2a–c), which co-expressed SαA (Fig. 2d, e, h–k) and cTnT (Fig. 2f, g, l) and by virtue of their size, gross morphology and inherent ultrastructure resembled mature cardiomyocytes (Fig. 2d–l). Whereas a relatively small number of Isl1+ progenitors were evident in Tβ4-primed, sham-operated hearts (Fig. 1n), we failed to locate any mature GFP+/YFP+ cardiomyocytes in the absence of injury (sham) or Tβ4 priming (data not shown). The de novo cardiomyocytes appeared appropriately integrated with the resident myocardium and with each other, as determined by both N-cadherin (Ncad)+ adherens junctions (Fig. 2f–i) and connexin 43 (Cx43)+ gap junction formation (Fig. 2j, k). Structurally coupled mature cTnT+/YFP+ cardiomyocytes were evident proximal to the scar and within the border zone (Fig. 2l). Consistent with tracking labelled cardiomyocytes from progenitors, proliferating BrdU+ cells at day 4 (Supplementary Fig. 9a–d) were traced to BrdU+/YFP+ cardiomyocytes at day 14 (Supplementary Fig. 9e–h). The total mean percentage of YFP+ progenitors that became cardiomyocytes was 0.59 ± 0.18% (serial sections through n = 7 hearts ± s.e.m.). The mean ratio of YFP+ de novo cardiomyocytes to YFP− pre-existing cardiomyoctes residing in the peri-infarct region (Fig. 2b) was 0.066 (1:15; ± 0.0015; six hearts analysed). In addition, from the two-photon imaging we were able to identify numbers of YFP+ cardiomyocytes (192.5 ± 12.1; four hearts analysed) in the underlying myocardium of the left ventricular wall up to a depth of ≤100 μm. Approximately 82% of YFP+ cardiomyoctes were located proximal to the site of injury, residing within either the border zone or the immediate surrounding healthy myocardium (Fig. 2c, l and Supplementary Fig. 10a–c).
To assess functional integration with resident myocardium, we recorded cellular calcium transients [Ca2+]i between YFP+ and YFP− cells in situ, as previously described13 (Fig. 2m–s and Supplementary Fig. 10a–f). Two-photon imaging confirmed migration of YFP+ cells from the outer epicardial layer into the underlying myocardium (Supplementary Fig. 7m). At day 14 after myocardial infarction, evoked [Ca2+]i transients in YFP+ cardiomyocytes were synchronous, with kinetics indistinguishable from those of neighbouring YFP− cardiomyocytes (Fig. 2q–s). Apparent differences in resolution between resident YFP− and de novo YFP+ cardiomyocyte transients (compare Fig. 2q with r) were observed, reflecting the newly acquired function of the YFP+ population.
To rule out the possibility that we traced resident cardiomyocytes that were labelled by virtue of ectopic activation of the fluorophore from the Wt1 knock-in alleles, we carried out a series of experiments transplanting FACS-isolated donor GFP+ cells into non-transgenic host hearts. Extensive analyses indicated that the prospective donor cells were progenitors of epicardial origin (Fig. 3). Wt1+ cells were restricted to the epicardium and subepicardial region throughout the heart, as confirmed by co-staining with an antibody against podoplanin, a transmembrane glycoprotein14 that specifically marked the epicardial and myocardial boundaries (Fig. 3a, b). Immunostaining for anti-GFP revealed GFP+ cells residing in the expanded epicardium but excluded from the myocardium throughout the heart (Fig. 3c, e). Real-time quantitative polymerase chain reaction analyses on FACS-isolated donor cells at day 4 revealed no expression of the canonical cardiomyocyte markers cTnT, MyBPC and Actn2 (Fig. 3d). We also analysed hearts isolated from Tβ4-primed/injured MLC2vCre/+;R26REYFP/+ mice (MLC2v–YFP; Fig. 3f), which lineage-traced ventricular cardiomyocytes as YFP+ from early developmental stages15 to adulthood, and confirmed an absence of Wt1 in both healthy and scarred myocardium respectively (Fig. 3g, h).
In a previous study, Wt1 was shown to be expressed in the coronary vasculature after myocardial infarction in the rat heart16. Co-immunostaining for Wt1 or GFP with Pecam and Flk1, respectively, excluded Wt1 expression in both coronary veins and arteries within the donor hearts and ruled out the possibility of the GFP+ progenitor population arising from existing vasculature (Fig. 3i, j). The FACS-isolated cells at day 4 revealed no expression of the canonical vascular markers Pecam and Tie2 (Fig. 3k), and cytospin with comparative immunostaining of the sorted GFP+ and GFP− populations (Fig. 3l) revealed that the GFP+ cells were negative for both vascular markers Pecam and SMA and myocardial markers SαA and cTnT (Fig. 3m), whereas the GFP− population contained cardiovascular cells (Fig. 3n).
After donor cell transplantation (Fig. 4a), GFP+ cells within the epicardial region of the host were restricted to the site of injection after 24 h (Fig. 4b). By day 7, GFP+/Nkx2-5+ donor cells, indicative of myocardial progenitor commitment, were located proximal to the subepicardium (Fig. 4c), in conjunction with morphologically immature, cTnT+ cardiomyocyte-like cells (Fig. 4d). Collectively, the presence of these staged donor derivatives suggested progressive differentiation towards a mature cardiomyocyte fate. More definitive donor GFP+ cardiomyocytes with myofibrillar structure and that co-expressed cTnT were observed residing within the host myocardium at day 14 (Fig. 4e, f). We subsequently traced donor GFP+ cardiomyocytes for fluorescent in situ hybridization (FISH) with X- and Y-chromosome paints to assess karyotype (Fig. 4a). Single XY GFP+ cardiomyocytes were detected within the XX host, indicating that transdifferentiation had occurred in the absence of cell fusion (predicted XYXX fusion karyotype; Fig. 4g–j). To exclude the possibility of reductive divisions of fusion hybrids accounting for the XY diploid karyotype, reciprocal transplantation experiments injecting female XX GFP+ donor cells into male XY wild-type hosts (Fig. 4k) resulted in XX GFP+/SαA+ cardiomyocytes (Fig. 4l, m) in XY host myocardium (Fig. 4n, o). Quantitative assessment of FISH on GFP+ cardiomyocytes (total n = 22) excluded the presence of a host Y chromosome in each case. Finally, we reanalysed non-transplanted YFP+ cells in female hearts (see Fig. 2) and detected examples of both YFP+/cTnT+ (Fig. 4p) and YFP+/SαA+ (Fig. 4r) cardiomyocytes with a single XX karyotype (Fig. 4q, s).
To investigate the outcome of Tβ4 priming on cardiac function and myocardial regeneration, we carried out serial magnetic resonance imaging (MRI) 7, 14 and 28 days after myocardial infarction (Supplementary Fig. 11a–e and Supplementary Table 1). Significant improvement in functional parameters, including ejection fraction and end diastolic/systolic volumes, alongside beneficial changes in infarct/scar volume with increased left ventricular mass over time (Supplementary Table 1) were recorded with Tβ4 treatment, as a surrogate indicator of replenished myocardium (Supplementary Fig. 11f, g).
Collectively, these data indicate that the adult heart can respond to injury with a modest increase in Wt1+ progenitors but without initiating a cardiogenic program. Tβ4 enhances this response, via a precocious and significant reactivation of Wt1 expression ultimately resulting in cardiomyocyte restitution. Although we cannot unequivocally exclude the possibility that Wt1+ progenitors arise from a nonepicardial source, support for an adult EPDC myocardial contribution comes from the tight regulation of Wt1+ labelling in the epicardium and subepicardial region, and transplantation of donor GFP+ progenitors residing both within and immediately proximal to the epicardium.
Reactivation of Wt1 by injury and Tβ4 represents a robust means to faithfully tag the progression of adult cardiac progenitors to differentiated myocytes, and provides mechanistic insight into a molecular function of Tβ4 and downstream cellular events. Previously, Tβ4 was shown to upregulate ILK and Akt activity in the heart, enhancing early myocyte survival after ischaemic injury17. In addition, Tβ4 can induce the adult epicardium, in the same setting, to contribute coronary endothelial and smooth muscle cells and initiate vascular repair6, 18. We now propose a further contribution, underpinning the initiation and migration of resident cardiovascular progenitors towards a cardiomyocyte fate. Although in the current study it is not possible to discriminate the relative contribution of each these proposed functions, several effects of Tβ4 seem to be delineated with time post-myocardial infarction. The pro-survival activity of Tβ4 is an early injury response to maintain the status quo of surviving myocardium, whereas the neovascularization and de novo cardiogenesis are longer-term regenerative functions potentially acting through the common target of adult EPDCs.
The identification of a bona fide source of myocardial progenitors is a significant step towards resident-cell-based therapy for acute myocardial infarction in human patients. The induced differentiation of the progenitor pool described into cardiomyocytes by Tβ4 is at present an inefficient process relative to the activated progenitor population as a whole. Consequently, the search is on via chemical and genetic screens to identify efficacious small molecules and other trophic factors to underpin optimal progenitor activation and replacement of destroyed myocardium.
Generation of epicardial trace mice
Wt1GFPCre/+ mice have been previously described4. Inducible Wt1CreERT2/+;R26REYFP/+ mice were generated by crossing the Wt1CreERT2/+ strain with Rosa26REYFP/+ reporter mice and genotyping as previously described. Adult mice were primed with intraperitoneal (i.p.) injection of Tβ4 or vehicle (PBS) into either Wt1GFPCre/+ or Wt1CreERT2/+;R26REYFP/+ (plus tamoxifen) strains. Primed mice were subsequently given a myocardial infarction by coronary artery ligation (n = 85, Wt1GFPCre/+ and n = 31, Wt1CreERT2/+;R26REYFP/+). Half of each myocardial infarction group were pre-treated with Tβ4 and half were vehicle treated (n = 6 sham-operated controls were included per experiment). Hearts were subsequently assessed using a combination of FACS, cytospin, immunofluorescence and real-time qRT–PCR analyses for GFP/YFP expression and myocardial markers after 2, 4, 7 and 14 days (see schematic in Fig. 1a). With respect to monitoring progenitor-derived cardiomyocytes the focus was on the inducible Wt1CreERT2/+;R26REYFP/+ model to ensure specific temporal labelling of YFP+ derivatives and rule out ectopic activation of the Wt1 gene at the targeted allele. Mice that were PBS treated with tamoxifen and Tβ4 primed in the absence of tamoxifen were used as controls and importantly we never observed YFP+ cardiomyocyte-like cells in these hearts.
Generation of MLC2vCre/+; R26REYFP/+ mice
MLC2vCre/+ mice have been described previously15 and were crossed with the R26REYFP/+ strain to generate MLC2v–YFP mice for myocardial infarction and to exclude Wt1 upregulation in YFP+ cardiomyocytes.
Adult epicardial explant cultures
Adult EPDCs were prepared, as previously described7, from 8–10-week-old Wt1GFPCre/+ mice that had received daily i.p. injections of Tβ4 (RegeneRX, 12 mg kg−1 in PBS) or vehicle (PBS) for 7 days. Cells were allowed to differentiate for up to 14 days in Iscove’s modified Dulbecco’s medium (IMDM) containing 20% FBS, before fixing in 4% paraformaldehyde for immunostaining analysis. At the outset GFP+ cells were recorded emerging from Tβ4-treated explants (66.8 ± 4.5; mean percentage of GFP+ cells relative to total number of cells in outgrowth ± s.e.m.; n = 12 explants). Outgrowing cells, up to 6 days in culture, were documented as immature and phenotypically similar to Nkx2-5+ progenitors previously isolated from embryonic hearts10 (Supplementary Fig. 2a–d). Throughout the ex vivo studies, PBS (vehicle)-treated explants were used as controls and revealed limited outgrowth or emergence of a significantly reduced number of GFP+ progenitor-like cells. The percentage incidence of GFP+ progenitors in the PBS treated/control explant cultures was recorded as 14.3 ± 1.9% (mean ± s.e.m.; n = 12), significantly lower (P ≤ 0.001) than those primed by Tβ4. Importantly, vehicle-treated cells failed to adopt a myocardial fate and only isolated fibroblast-derivatives were observed in control cultures (not shown).
Despite evidence of sarcomeric marker expression (cTnT, SαA and MyBPC) after Tβ4 treatment we did not observe beating in culture of the more differentiated cardiomyocyte-like cells documented. Because spontaneous contraction in vitro is confined to immature fetal or neonatal cardiomyocytes20, this may reflect a more mature adult myocyte phenotype.
The injection regimen of Tβ4 for priming Wt1GFPCre/+ and Wt1CreERT2/+;R26REYFP/+ mice, including induction with tamoxifen is outlined in Fig. 1a. In separate experiments, MLC2vCre/+;R26REYFP/+ and wild-type C57BL/6J mice were subject to the same injection regimen for epicardial priming. Adult mice received i.p. injection of Tβ4 (12 mg kg−1) or vehicle (PBS) daily for 7 days. On the eighth day Wt1CreERT2/+;R26REYFP/+ mice were injected with tamoxifen (2 mg suspended in peanut oil; i.p.) to induce CreERT2/Cre expression. Further injections of Tβ4/vehicle were given on day 9 and tamoxifen on day 10. Myocardial infarction was performed 3 days after this regimen.
Mice were housed and maintained in a controlled environment. All surgical and pharmacological procedures were performed in accordance with the Animals (Scientific Procedures) Act 1986, (Home Office, UK). For all experiments adult male Wt1GFPCre/+ (n = 85), Wt1CreERT2/+;R26REYFP/+ (n = 31), MLC2vCre/+R26REYFP/− mice (n = 5) and wild-type C57BL/6J mice (n = 21), (25–30 g) were primed with Tβ4 or vehicle, as described earlier, before surgical procedures. Myocardial infarction was induced in isoflurane-anaesthetized mice by permanent ligation of the left anterior descending artery (LAD). Sham controls (suture passed under the LAD but not ligated) were performed in Wt1GFPCre/+ mice (n = 6) and Wt1CreERT2/+;R26REYFP/+ mice (n = 6). On recovery, animals received i.p. injection of Tβ4 (12 mg kg−1) or vehicle (PBS). Further injections were given every second day. For pulse chase BrdU experiments, Wt1GFPCre/+ and Wt1CreERT2/+;R26REYFP/+ mice were injected i.p. with 200 μl of BrdU labelling reagent (Zymed, Invitrogen) on recovery and at 2 and 4 days after LAD ligation. Hearts were harvested at 2, 4, 7 and 14 days after ligation and bisected transversely midway through the scar: the apex was snap frozen for RNA isolation and subsequent real-time qRT–PCR studies while the remaining tissue was fixed in 4% PFA for cryosectioning and immunostaining analyses.
GFP+/YFP+ cell isolation and characterization
Hearts from Wt1GFPCre/+ and Wt1CreERT2/+;R26REYFP/+ mice treated with Tβ4 or vehicle were harvested 7 days after ligation and processed by enzymatic digestion using a 0.1% collagenase II-PBS solution (Worthington Biochemicals) to achieve a single-cell suspension. GFP+ or EYFP+ cells were isolated from the total cardiac cell population using a Beckman Coulter MoFlo XDP cell sorter with a 488 nm laser beam to excite YFP/GFP (collected in the 530/40 nm channel) and a 355 nm laser beam used to excite DAPI (collected in the 450/50 nm channel).
To characterize GFP+ cells, hearts from Wt1GFPCre/+ mice treated with Tβ4 were harvested 4 days after ligation and processed, as described earlier, to obtain a single-cell suspension. As a control, hearts from uninjured Wt1GFPCre/+ mice treated either with Tβ4 or with vehicle were also analysed after 7 days. Cells were incubated with the following primary and secondary antibodies: c-Kit (goat IgG, R&D System), Sca-1 (rat IgG2a, BD Pharmigen), Alexa Fluor 647 anti-goat or Alexa Fluor 647 anti-rat (Invitrogen) and analysed using a Beckman Coulter CyAn ADP analyser equipped with a 488 nm laser and 633 nm red diode and run by Summit Software. Data were analysed using the FlowJo Software.
Cell cytospins were collected using a Shandon Cytospin 3 centrifuge. Cytospun cells were then processed for immunostaining for epicardial and cardiovascular markers as described earlier.
YFP+ cardiomyocytes were assessed by cell counts through serial sections. The mean percentage of YFP+ progenitors that became cardiomyocytes was estimated across n = 7 hearts ± s.e.m. The incidence of YFP+ de novo cardiomyocytes relative to pre-existing myocardium was expressed as the mean ratio of YFP+ cells divided by YFP− cells across serial sections per heart ± s.e.m. (n = 6 hearts analysed). Cell counts were also assessed after two-photon imaging in Langendorff-perfused hearts and expressed as the mean number of YFP+ cardiomyocytes per heart ± s.e.m. (n = 4 hearts analysed).
Immunofluorescence was performed on adult epicardial explant cultures, on cytospun FACS-sorted cells and on cryosections of post-myocardial infarction hearts using standard protocols with the following antibodies: GFP (Clontech and Abcam, which also detect EYFP), SαA (Sigma), cardiac MyBPC (a gift from E. Ehler and M. Gautel), cTnT, cTNI, BrdU, Isl1 and Wt1 (all Abcam), Nkx2-5 (Santa Cruz), phospho-histone H3 (Upstate), podoplanin (Fitzgerald Industries) and Ki67 (Dako). To rule out the possibility of autofluorescence accounting for the detection of either GFP or YFP protein expression, sections through the left ventricle were stained with a polyclonal anti-GFP antibody (which detects both fluorescent proteins). The specificity of the anti-GFP antibody was ascertained by immunofluorescence on non-primed, intact hearts, which detected neither labelled cells in the epicardial region, nor their derivatives (no signal; not shown).
To detect BrdU-positive nuclei, sections were treated with 2 N HCl for 30 min at room temperature (22 °C) to denature the DNA, and neutralized in 0.1 M sodium borate pH 8.5 for 12 min before incubation with the anti-BrdU antibody. Owing to the destruction of cellular antigens resulting from acid treatment, these steps were performed after the incubation with antibodies to GFP and SαA. Images were acquired using either a Zeiss AxioImager with ApoTome or a Zeiss LSM 710 confocal microscope equipped with argon and helium neon lasers using ×20, ×40 and ×63/1.4 (oil immersion) objectives.
RNA in situ hybridization
RNA isolation and gene expression profiling
Total RNA was isolated from the apex of collected hearts using the Trizol reagent (Invitrogen), according to the manufacturer’s instructions and reverse-transcribed using Superscript III RT (Invitrogen). Real-time qRT–PCR analysis was performed on an ABI 7900 Sequence Detector (Applied Biosystems) using SYBR Green (QuantitectTM SYBR Green PCR Kit, Qiagen). Data were normalized to Hprt expression (endogenous control). Fold-changes in gene expression were determined by the 2−ΔΔCT method22 and are presented relative to levels in non-myocardial infarction (sham) hearts. Complementary DNA PCR primer sequences were obtained from Primer Bank (http://pga.mgh.harvard.edu/primerbank/) and details are available on request.
To characterize GFP+ progenitors, total RNA was obtained from FACS-sorted GFP+ cells isolated after enzymatic digestion of the hearts of the Tβ4-treated Wt1GFPCre/+ mice at 4 and 14 days following LAD ligation using a Beckman Coulter MoFlo XDP cell sorter. Total RNA was isolated using the RNeasy Micro Kit (Qiagen), according to the manufacturer’s instructions, and processed as above.
Multiphoton imaging was performed in Langendorff-perfused hearts loaded with Rhod- 2/AM (Invitrogen) as described previously19 except that 50 μM blebbistatin was used to inhibit myosin crossbridge cycling and prevent movement. Spontaneous calcium transients were visualized without electrical pacing. Images were recorded using a C-apochromat ×40/1.2 NA water-immersion objective on a Zeiss LSM NLO axiovert microscope coupled to a tunable Chameleon laser (Coherent) and external (nondescanned) detectors. EYFP/EGFP and Rhod-2/AM were excited simultaneously at 990 nm, which is long enough to avoid myofibril autofluorescence while strongly exciting the fluorochromes. Emitted light was collected using a bandpass 500–550 nm and 575–640 nm. Calcium transients were calculated by averaging along a line 40 pixels wide using ImageJ (http://rsbweb.nih.gov/ij) software. The ImageJ fourier filter was used to remove noise of less than 3 pixels and three-dimensional images were constructed using Imaris (Bitplane).
Wt1CreERT2/+;R26REYFP/+ and wild-type C57BL/6J mice treated with Tβ4 or vehicle, were subjected to MRI assessment at 7 days after LAD ligation. Where infarct size was within the range of 15–40%, follow-up MRI analysis was performed on the same mice at 14 and 28 days post-myocardial infarction, to determine temporal changes in infarct size and cardiac function. Mice were anaesthetized with isoflurane (4%), placed onto an animal cradle and maintained at 37 ± 0.5 °C with oxygen and anaesthetics (1–2% isoflurane), supplied via a nose cone (1 l min−1). Cardiorespiratory monitoring and gating were performed using an MR-compatible system (SA Instruments) with needle electrodes inserted into the front limbs and a respiratory pillow placed on the chest. Imaging was performed using a 9.4T VNMRS horizontal bore scanner (Varian) with a shielded gradient system (1,000 mT m−1) using a 39 mm diameter volume coil (Rapid Biomedical GmbH). An electrocardiogram and respiratory gated spoiled gradient echo sequence was used to acquire cine cardiac images with the following parameters for standard cine acquisitions: Time to echo (TE), 1.18 ms; time to repetition (TR), 4.5 ms; flip angle, 20°; slice thickness, 1 mm; no slice separation, field of view (FOV), 25.6 × 25.6 mm2; matrix size, 128 × 128; number of signal averages (NSA), 2. Twenty cine-frames were recorded to cover the cardiac cycle. Infarct size was assessed using late gadolinium enhancement (LGE), as previously described23. Briefly, 0.6 mmol kg−1 Gd-DTPA was administered i.p. followed by a Look-Locker acquisition with multiple time to inversion (TI) to determine the optimum TI. This was followed by a multi-slice inversion recovery (IR) acquisition with flip angle (FA) = 90° using the following imaging parameters: TE, 1.58 ms; TR, ~500–600 ms; FA, 90°; slice thickness, 0.5 mm; 0.5 mm slice gap; 7–8 slices; FOV, 25.6 × 25.6 mm2; matrix size, 192 × 192; NSA, 2. A second stack of short-axis images offset by 0.5 mm was acquired to generate a continuous data set.
MR image analysis
Randomized and anonymized images were analysed using the cardiac analysis software Segment (http://segment.heiberg.se)24. To estimate the infarct size, endocardial and epicardial borders were segmented on LGE images automatically with manual adjustments followed by automatic delineation of infarct tissue using a built-in fraction of segment. Manual corrections were performed where necessary. Infarct size, expressed as percentage of left ventricular mass, was calculated as infarct volume/left ventricular volume (from cine data). Results are shown as mean ± s.e.m. Comparisons between groups were performed using a repeated measures one-way ANOVA. All statistical analysis was performed using R software25 version 2.8.1.
Adult male (n = 14) and female (n = 14) Wt1GFPCre/+ mice were primed with Tβ4 and myocardial infarction was induced as described earlier. Pooled GFP+ progenitors were isolated (from eight surviving donors) using a Beckman Coulter MoFlo XDP cell sorter after enzymatic digestion of the hearts of Tβ4-treated WT1GFPCre/+ mice 4 days after ligation. Female (n = 3) and male (n = 3) non-transgenic mice were treated with Tβ4 before surgery and myocardial infarction was induced as described above. 3–6 × 104 FACS-sorted male GFP+ cells, resuspended in 10 μl of DMEM, were injected into the subepicardial space of the female host hearts (n = 3) immediately after LAD ligation. On recovery, animals received i.p. injection of Tβ4 (12 mg kg−1). Further injections were given every second day and hearts were harvested 14 days post-myocardial infarction and processed for immunofluorescence analysis as described earlier. In the second set of experiments, 5 × 104 FACS-sorted female GFP+ cells, resuspended in 10 μl of DMEM, were injected into the subepicardial space of the male host hearts (n = 3) immediately after LAD ligation. On recovery, animals received i.p. injection of Tβ4 (12 mg kg−1). Further injections were given every second day and hearts were harvested at 24 h, 7 days and 14 days post-myocardial infarction and processed for immunofluorescence analysis.
After immunofluorescence analysis of EPDC-derived cardiomyocytes in adult heart cryosections, as described earlier, images were acquired before FISH. FISH was performed using mouse StarFISH probes (Cambio), essentially according to the manufacturer’s instructions, with the following modifications: muscle was digested in 0.025% pepsin for 40 min at 37 °C. After dehydration, tissue sections were denatured by immersion in 70% formamide at 72 °C for 5 min. Cy3-conjugated X- and FITC-conjugated Y-chromosome paints were mounted, sealed under coverslips and denatured by incubation at 60 °C for 10 min before hybridization in a humid chamber overnight at 37 °C. Coverslips were removed and sections were either washed, according to the manufacturer’s instructions, or, where Y-chromosome probes were used, a FITC amplification kit (Cambio) was used, according to the manufacturer’s instructions.
- Natural and synthetic regulators of embryonic stem cell cardiogenesis. Pediatr. Cardiol. 30, 635–642 (2009) , &
- Thymosin β4 induces adult epicardial progenitor mobilization and neovascularization. Nature 445, 177–182 (2007) et al.
- A myocardial lineage derives from Tbx18 epicardial cells. Nature 454, 104–108 (2008) et al.
- Epicardial progenitors contribute to the cardiomyocyte lineage in the developing heart. Nature 454, 109–113 (2008) et al.
- Tbx18 and the fate of epicardial progenitors. Nature 458, E8–E9 (2009) et al.
- Thymosin β4 mediated PKC activation is essential to initiate the embryonic coronary developmental program and epicardial progenitor cell activation in adult mice in vivo. J. Mol. Cell. Cardiol. 46, 728–738 (2009) et al.
- Derivation of epicardium-derived progenitor cells (EPDCs) from adult epicardium. Curr. Protoc. Stem Cell Biol. Unit 2C.2. (2009) &
- Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages. Nature 433, 647–653 (2005) et al.
- Multipotent embryonic Isl1+ progenitor cells lead to cardiac, smooth muscle, and endothelial cell diversification. Cell 127, 1151–1165 (2006) et al.
- Developmental origin of a bipotential myocardial and smooth muscle cell precursor in the mammalian heart. Cell 127, 1137–1150 (2006) et al.
- An Nkx2-5/Bmp2/Smad1 negative feedback loop controls heart progenitor specification and proliferation. Cell 128, 947–959 (2007) et al.
- Myocardial infarction induces embryonic reprogramming of epicardial c-kit+ cells: role of the pericardial fluid. J. Mol. Cell. Cardiol. 48, 609–618 (2010) et al.
- Two-photon molecular excitation imaging of Ca2+ transients in Langendorff-perfused mouse hearts. Am. J. Physiol. Cell Physiol. 284, C1654–C1668 (2003) et al.
- Cardiac malformations and myocardial abnormalities in podoplanin knockout mouse embryos: correlation with abnormal epicardial development. Dev. Dyn. 237, 847–857 (2008) et al.
- Ventricular muscle-restricted targeting of the RXRα gene reveals a non-cell-autonomous requirement in cardiac chamber morphogenesis. Development 125, 1943–1949 (1998) , &
- The Wilms’ tumor suppressor Wt1 is expressed in the coronary vasculature after myocardial infarction. FASEB J. 16, 1117–1119 (2002) et al.
- Thymosin β4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair. Nature 432, 466–472 (2004) et al.
- Thymosin β4 facilitates epicardial neovascularization of the injured adult heart. Ann. N. Y. Acad. Sci. 1194, 97–104 (2010) et al.
- Two-photon molecular excitation imaging of Ca2+ transients in Langendorff-perfused mouse hearts. Am. J. Physiol. Cell Physiol. 284, C1654–C1668 (2003) et al.
- Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors. Cell 142, 375–386 (2010) et al.
- Sensitive nonradioactive detection of mRNA in tissue sections: novel application of the whole-mount in situ hybridization protocol. J. Histochem. Cytochem. 49, 1–8 (2001) et al.
- Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method. Methods 25, 402–408 (2001) &
- Late gadolinium enhanced MRI in small animal models of myocardial infarction. J. Cardiovasc. Magn. Reson. 12 (Suppl. 1). P98 (2010) et al.
- Time resolved three-dimensional automated segmentation of the left ventricle. Comput. Cardiol. 32, 599–602 (2005) et al.
- R: a language for data analysis and graphics. J. Comput. Graph. Stat. 5, 299–314 (1996) &
This work was funded by the British Heart Foundation. We are grateful to F. Costantini and S. Srinivas for providing the R26R–EYFP mouse strain, to B. Vernay for assistance with confocal microscopy and A. Eddaoudi, P. Chana and A. Angheluta for assistance in flow cytometry. We thank A. Taylor and V. Muthurangu for functional interpretation of MRI data and RegeneRx Biopharmaceuticals for provision of clinical grade Tβ4.
- Supplementary Figures (1M)
The file contains Supplementary Figures 1-11 with legends. Supplementary Table 1 was added on June 30th 2011.